GSK position history
The shares of GSK that DODGE & COX reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2022 Q3: 58,583,989 shares, $1.7M, 1.3% of portfolio, New
- 2022 Q4: 64,932,952 shares, $2.3B, 1.6% of portfolio, Add +10.8%
- 2023 Q1: 69,707,068 shares, $2.5B, 1.7% of portfolio, Add +7.4%
- 2023 Q2: 69,611,268 shares, $2.5B, 1.7% of portfolio, Reduce −0.1%
- 2023 Q3: 69,281,183 shares, $2.5B, 1.7% of portfolio, Reduce −0.5%
- 2023 Q4: 138,053,586 shares, $5.1B, 3.2% of portfolio, Add +99.3%
- 2024 Q1: 68,862,308 shares, $3B, 1.7% of portfolio, Reduce −50.1%
- 2024 Q2: 68,337,138 shares, $2.6B, 1.6% of portfolio, Reduce −0.8%
- 2024 Q3: 68,087,163 shares, $2.8B, 1.6% of portfolio, Reduce −0.4%
- 2024 Q4: 68,440,912 shares, $2.3B, 1.3% of portfolio, Add +0.5%
- 2025 Q1: 78,651,833 shares, $3B, 1.7% of portfolio, Add +14.9%
- 2025 Q2: 78,757,869 shares, $3B, 1.7% of portfolio, Add +0.1%
- 2025 Q3: 78,403,734 shares, $3.4B, 1.8% of portfolio, Reduce −0.4%
- 2025 Q4: 68,517,969 shares, $3.4B, 1.8% of portfolio, Reduce −12.6%
- 2026 Q1: 58,662,974 shares, $3.2B, 1.8% of portfolio, Reduce −14.4%
- 2026 Q2: 48,197,514 shares, $2.5B, 1.3% of portfolio, Reduce −17.8%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|